Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat for refractory mycosis fungoides
CTR20130325Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Oct 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in cutaneous T-cell lymphoma (CTCL), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Oct 2015; status: completed.
02
Drugs
vorinostat
03
Conditions
cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on CTR20130325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130325.